Desafios da reabilitação em fibrodisplasia ossificante progressiva: relato de caso
DOI:
https://doi.org/10.11606/issn.2317-0190.v29iSupl.1a204901Keywords:
Myositis Ossificans, Patient Care Team, RehabilitationAbstract
A Fibrodisplasia Ossificante Progressiva (FOP) acarreta limitação gradual da amplitude de movimento articular pela osteogênese heterotópica progressiva em diversas estruturas do tecido conjuntivo como músculos, fáscias, ligamentos e tendões.
Downloads
References
Cappato S, Traberg R, Gintautiene J, Zara F, Bocciardi R. A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene. Mol Genet Genomic Med. 2021;9(10):e1774. Doi: https://doi.org/10.1002/mgg3.1774
De Brasi D, Orlando F, Gaeta V, De Liso M, Acquaviva F, Martemucci L, et al. Fibrodysplasia ossificans progressiva: a challenging diagnosis. Genes (Basel). 2021;12(8):1187. Doi: https://doi.org/10.3390/genes12081187
Gencer-Atalay K, Ozturk EC, Yagci I, Ata P, Delil K, Ozgen Z, Akyuz G. Challenges in the treatment of fibrodysplasia ossificans progressiva. Rheumatol Int. 2019;39(3):569-576. Doi: https://doi.org/10.1007/s00296-018-4179-x
Haga N, Nakashima Y, Kitoh H, Kamizono J, Katagiri T, Saijo H, et al. Fibrodysplasia ossificans progressiva: Review and research activities in Japan. Pediatr Int. 2020;62(1):3-13. Doi: https://doi.org/10.1111/ped.14065
Hoyer-Kuhn H, Schönau E. Pharmacotherapy in Rare Skeletal Diseases. Handb Exp Pharmacol. 2020;261:87-104. Doi: https://doi.org/10.1007/164_2019_305
Pignolo RJ, Cheung K, Kile S, Fitzpatrick MA, De Cunto C, Al Mukaddam M, et al. Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry. Bone. 2020;134:115274. Doi: https://doi.org/10.1016/j.bone.2020.115274
Rashid U, Bari A, Maqsood A, Naz S, Ahmad TM. Fibrodysplasia Ossificans Progressiva. J Coll Physicians Surg Pak. 2016;26(2):154-5.
Semler O, Rehberg M, Mehdiani N, Jackels M, Hoyer-Kuhn H. Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases. Paediatr Drugs. 2019;21(2):95-106. Doi: https://doi.org/10.1007/s40272-019-00330-0
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
